ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 108 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2021. The put-call ratio across all filers is 28.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $162 | +15.7% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $140 | -0.7% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $141 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 200 | +809.1% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 22 | -99.3% | 0.00% | – |
| Q3 2018 | $73,000 | +2.8% | 3,200 | 0.0% | 0.00% | – |
| Q2 2018 | $71,000 | -2.7% | 3,200 | 0.0% | 0.00% | – |
| Q1 2018 | $73,000 | -13.1% | 3,200 | 0.0% | 0.00% | – |
| Q4 2017 | $84,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q3 2017 | $72,000 | -18.2% | 3,200 | 0.0% | 0.00% | – |
| Q2 2017 | $88,000 | +14.3% | 3,200 | 0.0% | 0.00% | – |
| Q1 2017 | $77,000 | +16.7% | 3,200 | 0.0% | 0.00% | – |
| Q4 2016 | $66,000 | +247.4% | 3,200 | +357.1% | 0.00% | – |
| Q3 2016 | $19,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 4,387,590 | $46,772,000 | 15.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,091,749 | $43,618,000 | 5.75% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,439,613 | $15,346,000 | 2.36% |
| Selkirk Management LLC | 348,805 | $3,718,000 | 1.18% |
| Chicago Capital, LLC | 1,966,891 | $20,967,000 | 1.08% |
| Trellus Management Company, LLC | 46,834 | $499,000 | 0.51% |
| Cannell & Co. | 1,118,439 | $11,923,000 | 0.44% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $1,652,000 | 0.36% |
| Belpointe Asset Management LLC | 419,406 | $3,982,000 | 0.27% |
| TCI Wealth Advisors, Inc. | 55,586 | $593,000 | 0.23% |